Clinical MR mammography: Impact of hormonal status on background enhancement and diagnostic accuracy

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 183, Issue 5, 2011, Pages 441-447

  Baltzer, P A ^a   Dietzel, M ^a   Vag, T ^b   Burmeister, H ^a   Gajda, M ^a   Camara, O ^a   Pfleiderer, S O ^a   Kaiser, W A ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

backgroundenhancement; breast; DCE MRI; hormones; MR imaging; sensitivity and specificity

Indexed keywords

HORMONE;

ADULT; AGED; ARTICLE; BACKGROUND ENHANCEMENT; BREAST CANCER; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CONSENSUS; DIAGNOSTIC ACCURACY; FALSE POSITIVE RESULT; FEMALE; FEMALE GENITAL SYSTEM FUNCTION; HISTOPATHOLOGY; HORMONAL CYCLE PHASE; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMAGE ENHANCEMENT; MAGNETIC RESONANCE MAMMOGRAPHY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RADIOLOGIST; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; CONTRAST MEDIA; ESTROGENS; FEMALE; FIBROADENOMA; GADOLINIUM DTPA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MENSTRUAL CYCLE; MIDDLE AGED; NEOPLASM INVASIVENESS; PAPILLOMA; POSTMENOPAUSE; PROGESTERONE; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, MAMMARY; YOUNG ADULT;

EID: 79955572331     PISSN: 14389029     EISSN: 14389010     Source Type: Journal    
DOI: 10.1055/s-0029-1246072     Document Type: Article

References (20)

1. Kuhl C. The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 2007 244 356-378 (Pubitemid 47080868)
2. Houssami N, Ciatto S, Macaskill P et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008 26 3248-3258
3. Warner E, Messersmith H, Causer P et al. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 2008 148 671-679 (Pubitemid 351669112)
4. Baltzer P A., Dietzel M, Vag T et al. Can Color-Coded Parametric Maps Improve Dynamic Enhancement Pattern Analysis in MR Mammography? Fortschr Röntgenstr 2009 182 254-260
5. Kuhl C K., Mielcareck P, Klaschik S et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999 211 101-110 (Pubitemid 29161739)
6. Kaiser W A. False-positive results in dynamic MR mammography. Causes, frequency, and methods to avoid. Magn Reson Imaging Clin N Am 1994 2 539-555
7. Mann R M., Kuhl C K., Kinkel K et al. Breast MRI: guidelines from the European Society of Breast Imaging. European radiology 2008 18 1307-1318
8. Zeppa R. Vascular response of the breast to estrogen. The Journal of clinical endocrinology and metabolism 1969 29 695-700
9. Kuhl C K., Bieling H B., Gieseke J et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 1997 203 137-144 (Pubitemid 27142721)
10. Muller-Schimpfle M, Ohmenhauser K, Stoll P et al. Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 1997 203 145-149 (Pubitemid 27142722)
11. Pfleiderer S O., Sachse S, Sauner D et al. Changes in magnetic resonance mammography due to hormone replacement therapy. Breast Cancer Res 2004 6 R232-R238
12. Rieber A, Nussle K, Merkle E et al. MR mammography: influence of menstrual cycle on the dynamic contrast enhancement of fibrocystic disease. European radiology 1999 9 1107-1112
13. Lorenzen J, Welger J, Lisboa B W. et al. MR-Mammographie bei 0,5 Tesla: Menstruationszyklusabhangigkeit der Kontrastmittelanreicherung unter hormoneller Kontrazeption? Fortschr Röntgenstr 2003 175 502-506 (Pubitemid 36512559)
14. Ikeda D M., Hylton N M., Kuhl C K. et al. MRI Breast Imaging Reporting And Data System Atlas. Reston American College of Radiology 2003 1 ed.
15. Malich A, Fischer D R., Wurdinger S et al. Potential MRI interpretation model: differentiation of benign from malignant breast masses. AJR 2005 185 964-970
16. Teifke A, Hlawatsch A, Beier T et al. Undetected malignancies of the breast: dynamic contrast-enhanced MR imaging at 1.0T. Radiology 2002 224 881-888 (Pubitemid 34919827)
17. Delille J P., Slanetz P J., Yeh E D. et al. Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T 1 relaxation time of breast tissue. The breast journal 2005 11 236-241 (Pubitemid 41026036)
18. Chen J H., Liu H, Baek H M. et al. Magnetic resonance imaging features of fibrocystic change of the breast. Magnetic resonance imaging 2008 26 1207-1214
19. Jansen S A., Newstead G M., Abe H et al. Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade. Radiology 2007 245 684-691 (Pubitemid 350127338)
20. Neubauer H, Li M, Kuehne-Heid R et al. High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement. The British journal of radiology 2003 76 3-12 (Pubitemid 36236293)